INTRODUCTION
============

Ultrasound (US)-guided fine needle aspiration (FNA) is generally considered to be the gold standard for the diagnosis of thyroid nodules due to its simplicity, safety, cost-effectiveness, and diagnostic accuracy ([@B1]). Studies report a diagnostic sensitivity of 83--98% and specificity of 70--92% ([@B1][@B2]). However, the key disadvantage of FNA is the high rate of non-diagnostic and indeterminate cytology results, including atypia of undetermined significance (AUS) and follicular lesion of undetermined significance (FLUS), which occur in approximately 10--33.6% and 15--42% of all FNA samples, respectively ([@B3][@B4][@B5][@B6]). In addition, many studies indicate that the false-negative rate of FNA cytology with respect to thyroid cancers is insignificant; studies show the estimated malignancy rate of nodules with benign cytological results to be 3.7% ([@B7]) and 1--2% based on repeat FNA results or long-term follow-up ([@B8][@B9][@B10]). However, thyroid nodules that were benign on FNA cytology but had suspicious features on US had a higher false-negative rate of 13.6--56.6% ([@B9][@B11][@B12][@B13][@B14][@B15][@B16][@B17]).

To overcome the limitations of FNA, core needle biopsy (CNB) has been suggested as an alternative technique ([@B18][@B19][@B20]). Studies have established CNB as a feasible, safe, and well-tolerated technique that is associated with a low incidence of complications ([@B21][@B22][@B23]). Several recent studies demonstrated that CNB can effectively reduce the possibility of inconclusive results ([@B22][@B23][@B24]) and prevent unnecessary and/or diagnostic surgery ([@B22][@B23][@B25][@B26]). However, the role of CNB for the assessment of thyroid nodules with suspicious US features has not been well established. One study evaluated the malignancy risk of suspicious thyroid nodules that exhibited benign results on CNB ([@B27]). The study showed that CNB had a lower false-negative rate of 3.6--5.5% according to various US risk systems. However, the study design was retrospective and focused only on the false-negative rate of CNB. Therefore, the effectiveness and safety of CNB for suspicious thyroid nodules requires further evaluation, and this prospective study was designed to determine the potential merit of using CNB to assess thyroid nodules with suspicious US features.

MATERIALS AND METHODS
=====================

Study Population
----------------

The protocol for this prospective study was approved by the local Institutional Review Board. Consecutive adult patients (aged ≥ 18 years) who underwent US-guided CNB for thyroid nodules between May and August 2016 and who had at least one suspicious feature on US were enrolled in the study ([@B28]). Informed consent was provided by all patients.

US-Guided CNB
-------------

Ultrasound examination was performed using one of three systems: an iU22 or HDI-5000 unit (Philips Healthcare, Bothell, WA, USA), or an EUB-7500 unit (Hitachi Medical Systems, Tokyo, Japan). Each was equipped with a linear high-frequency probe (5--14 MHz). All US examinations and US-guided CNBs were performed by one of five radiologists supervised by two faculty radiologists with 21 years and 14 years of clinical experience in performing and evaluating thyroid US examinations, respectively.

Ultrasound-guided CNB was performed using a disposable 1.1- or 1.6-cm excursion, 18-gauge double action spring-activated needle (TSK Ace-cut; Create Medic, Yokohama, Japan) following local anesthesia with 2% lidocaine ([@B23][@B26]). Using a freehand technique, the core needle was advanced from the isthmus of the thyroid towards the nodule. After the tip of the needle had been advanced into the edge of the nodule, the distance of fire (1.1 cm or 1.6 cm) was measured before sequential firing of the stylet and cutting cannula of the needle. After applying firm local compression to the biopsy site for 10--20 minutes, patients underwent an observation period. If the patients complained of pain or neck swelling, US examination was repeated to evaluate complications ([@B29]).

Analysis of US Findings
-----------------------

In all patients, US examination was performed prior to CNB by one of the five radiologists under the supervision of the two faculty radiologists. Nodules were evaluated for the following features: internal composition (solid, predominantly solid, predominantly cystic, or cystic), shape (ovoid-to-round, taller-than-wide, or irregular), margin (smooth, spiculated, or ill-defined), echogenicity (isoechoic, hypoechoic, markedly hypoechoic, or hyperechoic), and the presence of microcalcification, macrocalcification, or rim calcification. Nodules with suspicious features on US examination were defined as those having at least one of following features: marked hypoechogenicity, microcalcification, spiculated margin, or taller-than-wide shape ([@B28]).

Analysis of CNB Histopathology
------------------------------

Core needle biopsy and surgical specimens were reviewed by a staff pathologist with 13 years\' experience of thyroid cytopathology. CNB results were categorized into six categories according to guidelines from the Korean Endocrine Pathology Thyroid Core Needle Biopsy Study Group ([@B30]). A non-diagnostic CNB reading (category I) included specimens with an insufficient number of follicular cells to provide an appropriate diagnosis and specimens that were not representative of the US image of the lesion (e.g., skeletal muscle and mature adipose tissue, virtually acellular specimen, acellular fibrotic nodule, or blood clot only). The benign category (category II) included all benign thyroidal and non-thyroidal diseases, such as benign follicular nodules (including nodular hyperplasia, follicular adenoma, colloid nodules, and nodules in Graves\' disease), Hashimoto\'s thyroiditis, subacute granulomatous thyroiditis, and non-thyroidal lesions (e.g., parathyroid lesions, benign neurogenic tumor, and benign lymph nodes). Category III were indeterminate lesions, subcategorized as indeterminate follicular lesions with nuclear atypia (IIIA) and indeterminate follicular lesions with architectural atypia (IIIB). Category IIIA included follicular proliferative lesions with focal nuclear atypia or atypical follicular cells embedded in fibrotic stroma; category IIIB included microfollicular proliferative lesions lacking a fibrous capsule or adjacent normal thyroid tissue in the specimen. Category IV included follicular neoplasms or cases where there was suspicion of a follicular neoplasm based on the presence of a fibrous capsule and microscopic features that differed from the adjacent thyroid parenchyma. The category for suspicion of malignancy (category V) included CNB readings with atypical features that were insufficient for definite diagnosis of malignancy. The malignancy category (category VI) referred to specimens that exhibited unequivocal features of cancer. Immunohistochemistry data were not used as the basis for these readings ([@B27]).

Reference Standard
------------------

Malignant nodules were diagnosed after surgery or after biopsy with specific pathologic results. Benign nodules were diagnosed either after surgery (with benign findings after FNA and/or CNB that had been repeated at least twice) or after benign findings at CNB with a stable size at 1-year follow-up.

Statistical Analysis
--------------------

Diagnostic performance and the incidence of non-diagnostic results, inconclusive results, conclusive results, malignancy, unnecessary surgery, and complications were analyzed. Diagnostic performance was determined by evaluating the diagnostic accuracy, sensitivity, specificity, positive predictive value, and negative predictive value of CNB for the diagnosis of malignancy. The inconclusive result rate was defined as the rate of non-diagnostic results and AUS or FLUS. The conclusive result rate was defined as the combined rate of benign, follicular neoplasms, specimens considered suspicious for a follicular neoplasm or for malignancy, and those having malignancy findings. Unnecessary surgery was defined as two clinical scenarios: 1) when nodules reported as malignant on CNB were confirmed as benign or 2) when nodules reported as follicular neoplasms on CNB were confirmed as adenomatous hyperplasia ([@B29]). Major and minor complications were identified according to the Society of Interventional Radiology definitions ([@B31][@B32]). An additional subgroup analysis was performed according to nodule size (\< 1 cm or ≥ 1 cm). Results after surgery were compared with those after CNB. Furthermore, a multivariate logistic regression analysis was performed to determine the independent risk factors associated with inconclusive results on CNB. The level of significance was defined as *p* \< 0.05, and statistical analysis was performed using SPSS 21.0 for Windows software (IBM Corp., Armonk, NY, USA).

RESULTS
=======

During the study period, a total of 158 thyroid nodules with suspicious features on US were underwent FNA or CNB in our institution. Data from 93 patients (74 female and 19 male) with 102 thyroid nodules who underwent CNB were included in the analysis. CNB was well tolerated in all patients, with no major or minor complications. All samples obtained from CNB were adequate for diagnosis. All nodules were solid; mean size was 1.1 ± 0.6 cm (range, 0.3--3.8 cm). Final diagnoses were obtained for 80 nodules (78.4%), including 65 malignant nodules and 15 benign nodules ([Table 1](#T1){ref-type="table"}). Of the 102 nodules evaluated, 22 (21.6%) had an indeterminate result on biopsy (category III \[n = 7\], IIIA \[n = 2\], IIIB \[n = 3\], IIIAB \[n = 2\], and category V \[n = 2\]) or did not have adequate follow-up to confirm the pathology of the nodule (n = 13). Malignant nodules were diagnosed after surgery (n = 54) or after biopsy (n = 11). Benign nodules were diagnosed either after surgery (n = 4) or after a benign finding on CNB with a stable size after at least 1 year of follow-up (n = 11).

Correlation of CNB Results with Final Diagnosis
-----------------------------------------------

Of 80 suspicious thyroid nodules with a final diagnosis, one nodule showed a discordant result between CNB and the pathological examination of the surgical specimen. One nodule initially diagnosed as a benign follicular nodule on CNB was confirmed as a papillary thyroid carcinoma in the pathological examination of the surgical specimen. The nodule was \< 1 cm in size with a maximal diameter of 4 mm on US. Review of the pathologic slides and US images to determine a possible cause for the discordance in the pathologic results suggested the main reason to be mis-targeting of thyroid nodules during CNB. None of the patients included in the study underwent unnecessary surgery.

Diagnostic Performance of CNB
-----------------------------

The study outcomes of CNB for suspicious thyroid nodules are summarized in [Table 2](#T2){ref-type="table"}. The conclusive result rate was 87.3% (89 of 102; 95% confidence interval \[CI\]: 78.8--92.8), whereas the inconclusive result rate was 12.7% (13 of 102; 95% CI: 7.2--21.2). The diagnostic accuracy, sensitivity, specificity, positive predictive value, and negative predictive value of CNB for diagnosis of malignancy were 95% (76 of 80; 95% CI: 87.7--98.6), 93.8% (61 of 65; 95% CI: 85.0--98.3), 100% (15 of 15; 95% CI: 69.8--100.0), 100% (61 of 61; 95% CI: 91.3--100.0), and 78.9% (15 of 19; 95% CI: 54.4--93.9), respectively. Subgroup analysis performed according to nodule size showed no statistically significant difference in the diagnostic performance between nodules \< 1 cm and nodules ≥ 1 cm.

Risk Factors Associated with Inconclusive Results
-------------------------------------------------

The results of the univariate and multivariate logistic regression analyses for the risk factors associated with inconclusive results on CNB are shown in [Table 3](#T3){ref-type="table"}. The results showed a statistically significant association between inconclusive results and nodule size and needle length.

DISCUSSION
==========

In this study, we prospectively enrolled consecutive patients who underwent CNB for suspicious thyroid nodules. CNB performed on suspicious thyroid nodules obtained a sufficient sample for diagnosis in all cases, and no patients underwent unnecessary surgery. CNB was associated with high diagnostic values for thyroid cancer, with sensitivity, specificity, and accuracy of 93.8%, 100%, and 95%, respectively. These findings suggest that CNB is an effective method for the diagnosis of suspicious thyroid nodules.

Fine needle aspiration is widely accepted as the firs-tline method for evaluating thyroid nodules. Unfortunately, unsatisfactory or non-diagnostic results present a dilemma for clinicians and radiologists managing thyroid nodules. The Bethesda System for Reporting Thyroid Cytopathology ([@B33]) recommends an ideal non-diagnostic rate of \< 10% of all FNAs; however, studies show that up to 21% of nodules have non-diagnostic results in initial FNA, with the figure being as high as 50--63% in repeat biopsies ([@B34][@B35][@B36][@B37]). Previous studies revealed that hypoechogenicity and the presence of calcification on US is related to a high rate of non-diagnostic results on FNA ([@B38][@B39]). Hypoechogenicity is related to an increased cell density ([@B38]) and calcification (especially macrocalcification), therefore making it difficult to penetrate with a fine needle and leading to the failure to obtain an adequate cell sample ([@B39]). These factors mean that a considerable proportion of suspicious thyroid nodules assessed by FNA result in an uncertain diagnosis. In this study, CNB showed no non-diagnostic results for suspicious thyroid nodules, and the inconclusive result was not influenced by US characteristics. Therefore, this study suggests that the diagnostic value of CNB is independent and not reliant on US characteristics.

For suspicious thyroid nodules with initially benign cytological results, false-negative specimens are a particular concern. One study showed that 28 (32.9%) of 85 suspicious thyroid nodules with benign FNA results were histologically upgraded according to CNB specimens and 27 (31.8%) were finally confirmed as malignant ([@B11]). In the present study, among 13 patients with a benign result on CNB, nodules of only one patient were subsequently confirmed as malignant (false-negative rate: 7.8%), the reason for this being mistargeting of the thyroid nodules. The relatively large tissue sample obtained by CNB is a well-acknowledged diagnostic strength. In addition, monitoring the procedure using real-time US and the ability to visually inspect the adequacy of the tissue core ([@B18]) also leads to a lower false-negative rate with CNB. Therefore, clinicians should carefully consider re-biopsy or diagnostic surgical procedures for patients with US-CNB pathology discordant thyroid nodules because the risk of malignancy is relatively low. However, Chung et al. ([@B27]) recommended re-biopsy for US-CNB pathology discordant thyroid nodules with more than two suspicious US features because the malignancy risk is significantly higher than in nodules with one suspicious US feature.

The false-positive rate of FNA results in thyroid cancer has been reported as 2--10% ([@B40][@B41][@B42]), with Hashimoto\'s thyroiditis being the most common cause of false-positive cytology. Misclassification of follicular and Hürthle cell adenomas as papillary carcinomas accounts for additional errors ([@B43]). For CNB, no false-positive results were noted in the present study.

The inconclusive result rate associated with CNB was relatively high (12.7%). This is, however, lower than the inconclusive result rate reported with FNA in previous studies (10--33.6%) ([@B3][@B4][@B5][@B6]). All of the inconclusive CNB results in the present study were indeterminate (category III). On multivariate logistic regression analysis, the inconclusive results were related to nodule size (larger size) and length of needle (1.1 cm). According to the pathologic reporting system of thyroid CNBs, if a fibrous capsule or adjacent normal thyroid tissue is not identified in a CNB specimen that shows a predominantly microfollicular or trabecular growth pattern, it is reasonable to classify the lesion as diagnostic category III because the presence or absence of a fibrous capsule cannot be determined ([@B30]). Therefore, in large nodules, biopsy using a short-length needle is likely to result in a higher inconclusive result rate due to limited evaluation of the capsule of the nodule. If biopsy is performed on a nodule suspected of having a capsule, it may be helpful to obtain a sample that includes the nodule, nodule capsule, and adjacent normal glandular tissue with a long-length needle ([@B44]).

This study has several limitations. First, we used a relatively small sample size and a control group was not included in the study. Further investigation with a larger sample size and direct comparison between CNB and FNA will be required to verify the results of the study. Second, among the 15 benign nodules, 11 were confirmed by a benign result on CNB and size stability by US at 1-year follow-up. As thyroid cancers can grow very slowly, this follow-up period may not be sufficient to exclude a slow-growing malignancy. However, the definition of a benign nodule was based on previous publications ([@B11][@B13][@B27][@B29]). Finally, this study was conducted in a single specialist center and different results may have been obtained in community hospitals with less experienced operators. However, the difference in operator experience did not affect the inconclusive result rate in this study.

In conclusion, this study demonstrates that CNB obtained sufficient samples for diagnosis in all cases and resulted in high diagnostic values for evaluating suspicious thyroid nodules. CNB was associated with a high rate of conclusive results, and no patients underwent unnecessary surgery based on the CNB results. These findings indicated that CNB is a promising diagnostic tool for suspicious thyroid nodules.
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###### CNB Results and Final Diagnosis for Suspicious Thyroid Nodules
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                              Total CNB (n = 102)   Final Diagnosis (n = 80)   CNB (≥ 1 cm) (n = 49)   Final Diagnosis (n = 40)            
  --------------------------- --------------------- -------------------------- ----------------------- -------------------------- -------- -----------
  Non-diagnostic              0                     0                          0                       0                          0        0
  Benign                      26 (25.5)             12 (80)                    1 (1.5)                 13 (26.5)                  7 (70)   0
  Indeterminate               13 (12.7)             3 (20)                     3 (4.6)                 9 (18.4)                   3 (30)   3 (10)
  FN or SFN                   0                     0                          0                       0                          0        0
  Suspicious for malignancy   5 (4.9)               0                          3 (4.6)                 2 (4.1)                    0        2 (6.7)
  Malignancy                  58 (56.9)             0                          58 (89.2)               25 (51)                    0        25 (83.3)

Data are number of nodules (%); percentages do not add up to 100% due to rounding. CNB = core needle biopsy, FN = follicular neoplasm, SFN = suspicious for follicular neoplasm

###### Study Outcomes of CNB for Suspicious Thyroid Nodules
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  Study Outcomes               Incidence, % (Total)   95% CI        Incidence, % (\< 1 cm)   95% CI        Incidence, % (≥ 1 cm)   95% CI        *P*
  ---------------------------- ---------------------- ------------- ------------------------ ------------- ----------------------- ------------- -------
  Non-diagnostic               0 (0 of 102)           0.0--4.5      0 (0 of 56)              0.0--8.0      0 (0 of 46)             0.0--9.6      
  Inconclusive                 12.7 (13 of 102)       7.2--21.2     7.1 (4 of 56)            2.3--18.1     19.6 (9 of 46)          9.9--34.4     0.116
  Conclusive                   87.3 (89 of 102)       78.8--92.8    92.9 (52 of 56)          81.9--97.7    80.4 (37 of 46)         65.6--90.1    0.116
  Malignancy                   59.8 (61 of 102)       49.6--69.2    62.5 (35 of 56)          48.5--74.8    56.5 (26 of 46)         41.2--70.8    0.682
  Diagnostic accuracy          95 (76 of 80)          87.7--98.6    97.6 (41 of 42)          87.4--99.9    92.1 (35 of 38)         78.6--98.3    0.342
   Sensitivity                 93.8 (61 of 65)        85.0--98.3    97.2 (35 of 36)          85.5--99.9    89.7 (26 of 29)         72.6--97.8    0.316
   Specificity                 100 (15 of 15)         69.8--100.0   100 (6 of 6)             42.1--100.0   100 (9 of 9)            55.5--100.0   1.0
   Positive predictive value   100 (61 of 61)         91.3--100.0   100 (35 of 35)           85.5--100.0   100 (26 of 26)          81.0--100.0   1.0
   Negative predictive value   78.9 (15 of 19)        54.4--93.9    85.7 (6 of 7)            42.1--99.6    75 (9 of 12)            42.8--94.5    1.0
  Unnecessary surgery          0 (0 of 57)            0.0--7.9      0 (0 of 30)              0.0--14.1     0 (0 of 27)             0.0--15.5     1.0

CI = confidence interval

###### Results of Univariate and Multivariate Analysis to Determine Risk Factors Associated with Inconclusive Results

![](kjr-20-158-i003)

  Variables                   Conclusive (n = 89)   Inconclusive (n = 13)   *P*, Univariate   *P*, Multivariate   
  --------------------------- --------------------- ----------------------- ----------------- ------------------- -------
  Age, years                  52 ± 14.2             51 ± 14.5               57 ± 10.8         0.218               
  Sex (male:female)           20:82                 16:73                   4:9               0.285               
  Nodule size, cm             1.1 ± 0.6             1.0 ± 0.5               1.5 ± 0.9         0.018               0.002
  \< 1.0, n (%)               49 (55.1)             4 (30.8)                0.071                                 
  ≥ 1.0, n (%)                40 (44.9)             9 (69.2)                                                      
  Composition, n (%)          Solid                 89 (100)                13 (100)                              
  Shape, n (%)                Ovoid-to-round        55 (61.8)               11 (84.6)         0.221               
  Taller than wide            33 (37.1)             2 (15.4)                                                      
  Irregular                   1 (1.1)               0 (0)                                                         
  Margin, n (%)               Smooth                8 (9.0)                 2 (15.4)          0.391               
  Spiculated                  65 (73.0)             7 (53.8)                                                      
  Ill-defined                 16 (18.0)             4 (30.8)                                                      
  Echogenicity, n (%)         Isohyperechoic        4 (4.5)                 2 (15.4)          0.317               
  Hypoechoic                  45 (50.6)             7 (53.8)                                                      
  Markedly hypoechoic         40 (44.9)             4 (30.8)                                                      
  Calcification, n (%)        None                  24 (27.0)               4 (30.8)          0.319               
  Microcalcifications         57 (64.0)             9 (69.2)                                                      
  Macrocalcifications         8 (9.0)               0 (0)                                                         
  Number of biopsies, n (%)   1                     83 (93.3)               12 (92.3)         0.899               
  2                           6 (6.7)               1 (7.7)                                                       
  Length of needle, n (%)     1.1 cm                81 (91.0)               12 (92.3)         0.878               0.049
  1.6 cm                      8 (9.0)               1 (7.7)                                                       
  Operator, n (%)             Staff                 58 (65.2)               7 (53.8)          0.193               
  Fellow                      31 (34.8)             6 (46.2)                                                      
